Effect of Sglt2 Inhibitor Use in Ischemic Stroke Patients with Atrial Fibrillation without Diabetes or Heart Failure: Rationale and Design of a Randomized Controlled Trial

  • Lee, Meng (PI)
  • Chang, Jill (CoPI)
  • Chen, Wei-Tse (CoPI)
  • Hsieh, Tingyu (CoPI)
  • Hsu, Chengyang (CoPI)
  • Huang, Yen-Chu (CoPI)
  • Huang, Chia Yu (CoPI)
  • Hung, Shin Yi (CoPI)
  • Jeng, Wen-Yi (CoPI)
  • Lee, Jiann-Der (CoPI)
  • Lin, Sung Chun (CoPI)
  • Liou, Jiann-Shing (CoPI)
  • Liu, Chia Wei (CoPI)
  • Pan, Kuo-Li (CoPI)
  • Pan, Chih-Hao (CoPI)
  • Sung, Chi-Hung (CoPI)
  • Tang, Sheng-Feng (CoPI)

Project: National Science and Technology Council › National Science and Technology Council Academic Grants

Project Details

Abstract

對於40歲及以上無糖尿病且無心衰竭的缺血性中風伴AF患者中,如果SGLT2抑制劑加標準治療方案相比僅標準治療有更好的療效且有差不多的安全性,那這群病人除了使用直接口服抗凝劑(DOAC)等標準療法之外,加上SGLT2抑制劑能提供額外的好處。

Project IDs

Project ID:PC11307-1398
External Project ID:NSTC113-2314-B182-063
StatusActive
Effective start/end date01/08/24 → 31/07/25

Keywords

  • ischemic stroke
  • atrial fibrillation
  • SGLT2 inhibitor
  • nondiabetic
  • randomized controlled trial

Access Project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint